Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Daniel G. Coit; John A. Thompson; Mark R. Albertini; Christopher Barker; William E. Carson; Carlo Contreras; Gregory A. Daniels; Dominick DiMaio; Ryan C. Fields; Martin D. Fleming; Morganna Freeman; Anjela Galan; Brian Gastman; Valerie Guild; Douglas Johnson; Richard W. Joseph; Julie R. Lange; Sameer Nath; Anthony J. Olszanski; Patrick Ott; Aparna Priyanath Gupta; Merrick I. Ross; April K. Salama; Joseph Skitzki; Jeffrey Sosman; Susan M. Swetter; Kenneth K. Tanabe; Evan Wuthrick; Nicole R. McMillian; Anita M. Engh

doi:10.6004/jnccn.2019.0018

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Daniel G. Coit
, John A. Thompson
, Mark R. Albertini
, Christopher Barker
, William E. Carson
, Carlo Contreras
, Gregory A. Daniels
, Dominick DiMaio
, Ryan C. Fields
, Martin D. Fleming
, Morganna Freeman
, Anjela Galan
, Brian Gastman
, Valerie Guild
, Douglas Johnson
, Richard W. Joseph
, Julie R. Lange
, Sameer Nath
, Anthony J. Olszanski
, Patrick Ott

Aparna Priyanath Gupta, Merrick I. Ross, April K. Salama, Joseph Skitzki, Jeffrey Sosman, Susan M. Swetter, Kenneth K. Tanabe, Evan Wuthrick, Nicole R. McMillian, Anita M. Engh

Memorial Sloan-Kettering Cancer Center
Seattle Cancer Care Alliance
University of Wisconsin-Madison
Ohio State University
University of Alabama at Birmingham
University of California at San Diego
University of Nebraska Medical Center
Washington University St. Louis
University of Tennessee Health Science Center
City of Hope National Medical Center
Yale University
Case Western Reserve University
AIM
Vanderbilt University
Mayo Clinic
Johns Hopkins University
University of Colorado Cancer Center
Dana-Farber/Brigham and Women's Cancer Center
Northwestern University
University of Texas MD Anderson Cancer Center
Duke University
Roswell Park Comprehensive Cancer Center
Stanford University
Massachusetts General Hospital Cancer Center
University of South Florida
National Comprehensive Cancer Network

Research output: Contribution to journal › Article › peer-review

349 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.

Original language	English
Pages (from-to)	367-402
Number of pages	36
Journal	Journal of the National Comprehensive Cancer Network : JNCCN
Volume	17
Issue number	4
DOIs	https://doi.org/10.6004/jnccn.2019.0018
State	Published - Apr 1 2019

Keywords

Humans
Medical Oncology/standards
Melanoma, Cutaneous Malignant
Melanoma/diagnosis
Skin Neoplasms/diagnosis

Access to Document

10.6004/jnccn.2019.0018

Cite this

Coit, D. G., Thompson, J. A., Albertini, M. R., Barker, C., Carson, W. E., Contreras, C., Daniels, G. A., DiMaio, D., Fields, R. C., Fleming, M. D., Freeman, M., Galan, A., Gastman, B., Guild, V., Johnson, D., Joseph, R. W., Lange, J. R., Nath, S., Olszanski, A. J., ... Engh, A. M. (2019). Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 17(4), 367-402. https://doi.org/10.6004/jnccn.2019.0018

@article{cc9e684719554df1809c9197e1588664,

title = "Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology",

abstract = "The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.",

keywords = "Humans, Medical Oncology/standards, Melanoma, Cutaneous Malignant, Melanoma/diagnosis, Skin Neoplasms/diagnosis",

author = "Coit, \{Daniel G.\} and Thompson, \{John A.\} and Albertini, \{Mark R.\} and Christopher Barker and Carson, \{William E.\} and Carlo Contreras and Daniels, \{Gregory A.\} and Dominick DiMaio and Fields, \{Ryan C.\} and Fleming, \{Martin D.\} and Morganna Freeman and Anjela Galan and Brian Gastman and Valerie Guild and Douglas Johnson and Joseph, \{Richard W.\} and Lange, \{Julie R.\} and Sameer Nath and Olszanski, \{Anthony J.\} and Patrick Ott and Gupta, \{Aparna Priyanath\} and Ross, \{Merrick I.\} and Salama, \{April K.\} and Joseph Skitzki and Jeffrey Sosman and Swetter, \{Susan M.\} and Tanabe, \{Kenneth K.\} and Evan Wuthrick and McMillian, \{Nicole R.\} and Engh, \{Anita M.\}",

year = "2019",

month = apr,

day = "1",

doi = "10.6004/jnccn.2019.0018",

language = "English",

volume = "17",

pages = "367--402",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Harborside Press",

number = "4",

}

Coit, DG, Thompson, JA, Albertini, MR, Barker, C, Carson, WE, Contreras, C, Daniels, GA, DiMaio, D, Fields, RC, Fleming, MD, Freeman, M, Galan, A, Gastman, B, Guild, V, Johnson, D, Joseph, RW, Lange, JR, Nath, S, Olszanski, AJ, Ott, P, Gupta, AP, Ross, MI, Salama, AK, Skitzki, J, Sosman, J, Swetter, SM, Tanabe, KK, Wuthrick, E, McMillian, NR & Engh, AM 2019, 'Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 17, no. 4, pp. 367-402. https://doi.org/10.6004/jnccn.2019.0018

TY - JOUR

T1 - Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

AU - Coit, Daniel G.

AU - Thompson, John A.

AU - Albertini, Mark R.

AU - Barker, Christopher

AU - Carson, William E.

AU - Contreras, Carlo

AU - Daniels, Gregory A.

AU - DiMaio, Dominick

AU - Fields, Ryan C.

AU - Fleming, Martin D.

AU - Freeman, Morganna

AU - Galan, Anjela

AU - Gastman, Brian

AU - Guild, Valerie

AU - Johnson, Douglas

AU - Joseph, Richard W.

AU - Lange, Julie R.

AU - Nath, Sameer

AU - Olszanski, Anthony J.

AU - Ott, Patrick

AU - Gupta, Aparna Priyanath

AU - Ross, Merrick I.

AU - Salama, April K.

AU - Skitzki, Joseph

AU - Sosman, Jeffrey

AU - Swetter, Susan M.

AU - Tanabe, Kenneth K.

AU - Wuthrick, Evan

AU - McMillian, Nicole R.

AU - Engh, Anita M.

PY - 2019/4/1

Y1 - 2019/4/1

N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.

AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Cutaneous melanoma have been significantly revised over the past few years in response to emerging data on immune checkpoint inhibitor therapies and BRAF-targeted therapy. This article summarizes the data and rationale supporting extensive changes to the recommendations for systemic therapy as adjuvant treatment of resected disease and as treatment of unresectable or distant metastatic disease.

KW - Humans

KW - Medical Oncology/standards

KW - Melanoma, Cutaneous Malignant

KW - Melanoma/diagnosis

KW - Skin Neoplasms/diagnosis

UR - https://www.scopus.com/pages/publications/85064408797

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000464942100011&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.6004/jnccn.2019.0018

DO - 10.6004/jnccn.2019.0018

M3 - Article

C2 - 30959471

SN - 1540-1405

VL - 17

SP - 367

EP - 402

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 4

ER -

Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this